Assessment of Surgically Removed Abdominal Wall Endometriomas

Endometriosis Outside Pelvis Clinical Trial

Official title:

Clinico-pathological Assessment of Surgically Removed Abdominal Wall Endometriomas

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04639063
• Other study ID #: PMS20-11-01
• Status: Completed
• Start date: October 17, 2020
• Est. completion date: December 20, 2020

Study information

• Verified date: March 2021
• Source: Al-Azhar University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

A retrospective review of all patients who underwent surgery for an anterior abdominal wall mass which confirmed by pathology examination as an endometrioma will be completely performed. The clinical data will be recorded and pathology report diagnosis will be correlated with the clinical data to assess the possible causes of endometrioma in the women treated in our tertiary hospital and the efficacy of the surgical excision.

Description:

Our hospital is a tertiary center for performing Cesarean sections, external endometriosis (Endometrioma) is a challenging complication for this operation, many treatment choices are available and the most common is the surgical excision, however recurrence could be seen after the surgical operation. We assess all patients who underwent surgical excision for abdominal wall endometriomas in our hospital by retrieving the medical files and pathology reports to study the possible age group,causes and duration of endometriomas. Also the rate of enodmetriomas among the previously experienced females with cesarean section operations. Pathological diagnosis tools will be also assessed.

Ethical approval was obtained from the local committee. Results will be statistically assessed using SPSS programm.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: December 20, 2020
• Est. primary completion date: December 15, 2020
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 15 Years to 65 Years

Eligibility

Inclusion Criteria:

• Female

• Surgically removed abdominal wall endometrioma

Exclusion Criteria:

• Male (very very rare to occur)

• medically treated enodmetrioma

• Outside treated patients

Related Conditions & MeSH terms

• Endometriosis
• Endometriosis Outside Pelvis

Intervention

Other:
• Microscopic examination using H&E stained slides
Reexamination of the stained slides of the patients from the hospital archive and adding a CD10 stain when required

Locations

Country	Name	City	State
Egypt	Abdulkarim Hasan	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Al-Azhar University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Positive for endometrioma	Presence of endometrial glands and stroma along with hemosidren pigment under microscopic examination, confirms the diagnosis and the case will be calculated and the related clinical data	1 day